Nagasaka, M., Facchinetti, F., Bigot, L., Brayé, F., Groves, M. R., Yosa, J., Wekken, A. V., Aldea, M., Besse, B., Planchard, D., Naltet, C., Katayama, R., Olaussen, K. A., Loriot, Y. and Friboulet, L. The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinib.
npj Precis. Oncol., in press (2026) |
Kurosaki, T., Suzuki, S., Watanabe, Y., Kenmotsu, H., Itoh, S., Yamaguchi, M., Shiono, A., Suzuki, T., Yokoyama, T., Toi, Y., Tanaka, H., Oki, M., Tsuda, T., Ichihara, E., Azuma, K., Tanaka, H., Arai, R., Uchibori, K., Miyauchi, E., Katayama, R. and Hayashi, H. Immune-related gene expression profiling and alectinib efficacy for patients with ALK-rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.
Lung Cancer, 216, 109416 (2026) |
Suenaga, M., Mashima, T., Kawata, N., Dan, S., Seimiya, H. and Yamaguchi, K. Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer.
ESMO Gastrointest. Oncol., 12, 100323 (2026) |
Kawamoto, S., Horiguchi, H., Torigoe, D., Wakita, M., Ito, K., Sugawara, S., Zhou, X., Mikawa, T., Park, J. H., Jung, B. K., Okumura, Y., Miyagawa, H., Maruya, M., Hori, N., Uemura, K., Sugimoto, M., Matsuda, M., Mochizuki, N., Kondoh, H., Takahashi, A., Oike, Y. and Hara, E. Reevaluating the senolytic activity of a GLS1 inhibitor and an anti-PD-1 antibody: toward greater reproducibility and methodological rigor.
EMBO Rep., in press (2026) |
Sakiyama, K., Kumegawa, K., Yang, L., Tanabe, M. and Maruyama, R. Long-term intermittent estradiol exposure induces epithelial-mesenchymal transition-like plasticity in MCF10A cells.
Biochem. Biophys. Res. Commun., 812, 153601 (2026) |
Bernardi, F., Torrejon, J., Basili, I., Van Ommeren, R., Marsaud, V., Yu, H., Talbot, J., Souphron, J., Indersie, E., Forget, A., Bonneau, B., Massiot, A., Alcazar, C., Figeac, L., Bonerandi, E., Cancila, G., Sirbu, O., Yadav, N., Mohanakrishnan, D., Lombard, B., Loew, D., Poullet, P., Liva, S., Lovino, M., Lin, I. H., Nakashima, T., Gharsalli, T., Nicolas, P. A., Yubuki, N., Ribas, R. A., Colsch, B., Chu-Van, E., Castelli, F., Sampaio, J. L., Leboucher, S., Lasgi, C., Besse, L., Soler, M. N., Lo Re, V., Planque, N., Abeysundara, N., Balin, P., Wang, H., Su, H., Wu, X., Cavalli, F. M. G., Saulnier, O., Ficarra, E., Di Marcotullio, L., Kumegawa, K., Maruyama, R., Kawauchi, D., Picard, D., Remke, M., Riffaud, L., Puiseux, C., Bouchoucha, Y., Huybrechts, S., Simbozel, M., Bourdeaut, F., Varlet, P., Puget, S., Blauwblomme, T., Andrianteranagna, M., Planchon, J. M., Dugourd, A., Saez-Rodriguez, J., Barillot, E., Servant, N., Martignetti, L., Rich, J., Kool, M., Pfister, S. M., Agnihotri, S., Suzuki, H., Fanjul, M., Wang, W. J., Tsai, J. W., Sun, R. C., Beccaria, K., Dufour, C., Sarry, J. E., Michealraj, K. A., Taylor, M. D. and Ayrault, O. Multiomic integration reveals tumoral heterogeneity of lipid dependence within lethal group 3 medulloblastoma.
Cancer Cell, 44, 383-404.e18 (2026) |
Miyatake, Y., Kamakura, T., Ikawa, T., Yanagiya, R., Kotaki, R., Kameda, K., Nasu, R. K., Okuyama, K., Hirano, K. I., Hosokawa, H., Hozumi, K., Ohtsuka, M., Kisikawa, T., Shibata, C., Otsuka, M., Maruyama, R., Ando, K., Kurosaki, T., Kawamoto, H. and Kotani, A. A single microRNA miR-195 rescues the arrested B cell development induced by EBF1 deficiency.
eLife, 13, RP101510 (2026) |
Furukawa, T., Kumegawa, K., Miyata, K., Takamatsu, M., Iesato, A., Saeki, S., Yang, L., Shibata, C., Takahara, T., Masuda, K., Mie, T., Okamoto, T., Takeda, T., Sasaki, T., Ozaka, M., Tanaka, M., Takahashi, S., Noda, T., Yao, R., Sasahira, N. and Maruyama, R. Patient-derived orthotopic xenograft models recapitulate the peritoneal dissemination of pancreatic cancer and delineate its transcriptional and regulatory programs.
J. Exp. Clin. Cancer Res., in press (2026) |
Nakayama, C., Fang, Q., Daigaku, Y., Aoi, Y., Ito, S., Takahashi, M., Shimatani, R., Minamisawa, T., Ozturk, Y., Kimura, H., Shilatifard, A., Tellier, M. and Nojima, T. NELF prevents transcriptional readthrough into DNA replication zones in cancer cells.
EMBO Rep., in press (2026) |
Tanaka, Y., Sakahara, M., Yamanaka, H., Natsume, Y., Kusama, D., Kumegawa, K., Yoshikawa, H., Abe, Y., Okabayashi, K., Matui, S., Kitagawa, Y., Koshikawa, N., Osumi, H., Shinozaki, E., Nagayama, S., Adachi, J., Maruyama, R. and Yao, R. Ribosome biogenesis as a potential therapeutic target in KRAS mutant colorectal cancer.
Nat. Commun., 17, 1224 (2026) |
